Suppr超能文献

全盆腔脏器切除术治疗局部晚期和复发性直肠癌:泌尿系统结局和不良事件。

Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: Urological Outcomes and Adverse Events.

机构信息

Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Department of Colorectal Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK.

出版信息

Eur Urol Focus. 2021 May;7(3):638-643. doi: 10.1016/j.euf.2020.06.008. Epub 2020 Jul 2.

Abstract

BACKGROUND

Little has been reported on urological complications of total pelvic exenteration (TPE) for locally advanced or recurrent rectal cancer.

OBJECTIVE

To assess urological reconstructive outcomes and adverse events in this setting.

DESIGN, SETTING, AND PARTICIPANTS: A total of 104 patients underwent TPE from 2004 to 2016 in this single-centre, retrospective study. Electronic and paper records were evaluated for data extraction. Mean follow-up was 36.5 mo.

INTERVENTION

TPE.

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

Urological complications were analysed using two-tailed t and chi-square tests, binary logistic regression analysis.

RESULTS AND LIMITATIONS

Sixty-three (61%) patients received radiotherapy prior to TPE. Incontinent diversions included ileal conduit (n = 95), colonic conduits (n = 4), wet colostomy (n = 1), and cutaneous ureterostomy (n = 1). Three patients had a continent diversion. The overall urological complication rate was 54%. According to Clavien-Dindo classification, 30 patients, five patients, and one patient had grade III, IV, and V complications, respectively. The commonest complication was urinary tract infection (in 32 [31%] patients). Anastomotic leaks were seen in 14 (13%) cases, of which eight (8%) were urinary leaks. Fistulas were seen in three (3%) patients, involving the urinary system. A return to theatre was required in 12 (12%) patients. Ureteroenteric strictures were seen in seven (7%). No differences were seen in urological outcomes in patients with primary or recurrent rectal cancer (p = 0.69), or by radiation status (p = 0.24). The main limitation is the retrospective nature of the study.

CONCLUSIONS

TPE is complex with recognised high risk of morbidity. In this cohort, there was no significant difference in outcomes between primary and recurrent disease, and surgery after radiation.

PATIENT SUMMARY

In this study, we assessed urological complications following total pelvic exenteration. Urinary complications affected more than half of patients. Urinary tract infection is the commonest risk. Approximately one-third of patients required surgical, radiological, or endoscopic intervention ± intensive care admission. Radiation prior to the operation did not affect urinary complications.

摘要

背景

局部晚期或复发性直肠肿瘤全盆腔廓清术(TPE)后泌尿系统并发症的报道较少。

目的

评估该情况下的泌尿系统重建结果和不良事件。

设计、地点和参与者:本单中心回顾性研究共纳入 2004 年至 2016 年间行 TPE 的 104 例患者。评估电子和纸质记录以提取数据。平均随访 36.5 个月。

干预措施

TPE。

观察指标和统计分析

采用双尾 t 检验和卡方检验分析泌尿系统并发症,采用二项逻辑回归分析。

结果及局限性

63 例(61%)患者在 TPE 前接受放疗。不可控的转流术包括回肠造口术(95 例)、结肠造口术(4 例)、湿造口术(1 例)和皮氏输尿管造口术(1 例)。3 例患者行可控转流术。总的泌尿系统并发症发生率为 54%。根据 Clavien-Dindo 分类,30 例、5 例和 1 例患者分别出现 III 级、IV 级和 V 级并发症。最常见的并发症是尿路感染(32 例[31%])。吻合口漏 14 例(13%),其中 8 例为尿漏。3 例患者发生泌尿系统瘘。12 例(12%)患者需要返回手术室。7 例(7%)患者发生输尿管肠吻合口狭窄。原发性或复发性直肠癌患者(p = 0.69)或放疗状态(p = 0.24)对泌尿系统结局无显著影响。主要局限性在于研究的回顾性。

结论

TPE 是一种复杂的手术,具有较高的发病率。在本队列中,原发性和复发性疾病以及放疗后的手术在结局方面没有显著差异。

患者总结

在这项研究中,我们评估了全盆腔廓清术后的泌尿系统并发症。泌尿系统并发症影响了一半以上的患者。尿路感染是最常见的风险。约三分之一的患者需要手术、放射或内镜干预,以及入住重症监护病房。术前放疗并未影响泌尿系统并发症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验